Atenolol treatment for severe Infantile Hemangiomas: a single-centre prospective study

J Eur Acad Dermatol Venereol. 2018 Mar;32(3):e117-e119. doi: 10.1111/jdv.14590. Epub 2017 Nov 6.

Authors

A Alexopoulos¹, I Thanopoulou¹, M Dakoutrou¹, E Georgiadou¹, G P Chrousos¹, T Kakourou¹

Affiliation

¹ First Department of Pediatrics, "Aghia Sofia" Children's Hospital, University of Athens, Athens, Greece.

PMID: 28921662
DOI: 10.1111/jdv.14590

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Adrenergic beta-1 Receptor Antagonists / adverse effects
Adrenergic beta-1 Receptor Antagonists / therapeutic use*
Atenolol / adverse effects
Atenolol / therapeutic use*
Female
Hemangioma / drug therapy*
Humans
Infant
Male
Prospective Studies
Treatment Outcome

Substances

Adrenergic beta-1 Receptor Antagonists
Atenolol